Can a breastfeeding mother safely use baclofen as a muscle relaxant, and what dosing and infant monitoring are recommended?

Baclofen Use During Breastfeeding

Baclofen can be used during breastfeeding with appropriate infant monitoring, as only minimal amounts transfer to breast milk (approximately 0.1% of the maternal dose), but mothers must observe their infants closely for sedation, poor feeding, and withdrawal symptoms.

Evidence for Safety

The FDA label states that "it is not known whether this drug is excreted in human milk" and recommends that "nursing should not be undertaken while a patient is on a drug" 1. However, this conservative stance is contradicted by actual pharmacokinetic data.

Key pharmacokinetic study: A 1981 gas chromatography-mass spectrometry study demonstrated that baclofen does transfer to breast milk, but the total amount excreted over 24 hours was approximately one-thousandth (0.1%) of the ingested maternal dose 2. The elimination from milk was delayed about 3 hours relative to serum, but concentrations remained extremely low.

Clinical Risks to Consider

Infant Withdrawal Syndrome

The most significant concern is neonatal withdrawal, which has been documented in case reports:

• One case described withdrawal seizures in a term infant exposed to maternal oral baclofen 3
• Withdrawal symptoms typically manifest within 1-4 days after abrupt discontinuation 4
• Symptoms include severe psychiatric disturbances, delirium, agitation, and autonomic instability 4

Acute Toxicity Risk

While less likely given low milk transfer, baclofen toxicity in infants could theoretically present with:

• CNS depression (most common manifestation in 68% of toxicity cases) 4
• Respiratory depression (21% of cases) 4
• Seizures (36% of cases) 4

Dosing Considerations

Maternal dose matters significantly:

• Low doses (≤30 mg/day): Lowest risk profile
• Medium doses (31-100 mg/day): Moderate risk
• High doses (>100 mg/day): Increased concern for infant effects 4

The 2020 Association of Anaesthetists guideline does not specifically address baclofen for breastfeeding women, focusing instead on anesthetic agents, analgesics, and sedatives [@1-10@]. This absence from major guidelines reflects limited data rather than established safety.

Recommended Monitoring Protocol

For the mother:

• Use the lowest effective dose
• Avoid abrupt discontinuation (taper if stopping)
• Time breastfeeding to occur just before the next dose (when maternal levels are lowest)

For the infant - observe for:

1. Sedation/drowsiness (most critical sign)
2. Poor feeding or weak suck
3. Decreased muscle tone or "floppiness"
4. Respiratory changes (slower or irregular breathing)
5. Irritability or jitteriness (potential withdrawal if mother stops baclofen)

Action threshold: If any of these signs appear, contact a medical professional immediately and consider temporarily holding breastfeeding until evaluation.

Clinical Decision Algorithm

If baclofen dose is ≤30 mg/day:

• Breastfeeding is reasonable with close infant monitoring
• Educate mother on warning signs
• Consider pediatric follow-up within 1-2 weeks

If baclofen dose is 31-100 mg/day:

• Breastfeeding possible but requires heightened vigilance
• Weekly infant weight checks initially
• Consider consultation with pediatrics

If baclofen dose is >100 mg/day:

• Seriously consider alternative feeding methods
• If breastfeeding continues, require close pediatric monitoring
• Document informed consent discussion about risks

Important Caveats

Avoid abrupt maternal discontinuation: Given that baclofen withdrawal can be severe 4, never advise stopping baclofen suddenly to "clear" it from milk. The maternal risks of withdrawal (seizures, severe psychiatric symptoms, autonomic instability) far outweigh theoretical infant risks from continued low-level exposure.

Premature infants: The single case report of baclofen withdrawal occurred in a preterm infant 3, suggesting this population may be at higher risk. Exercise additional caution with premature or low-birth-weight infants.

Duration of therapy: Chronic maternal use (as opposed to short-term) increases the theoretical risk of infant accumulation or dependence, though no data quantifies this risk.

The evidence base remains limited to one pharmacokinetic study and scattered case reports, but the extremely low milk transfer (0.1% of maternal dose) 2 suggests baclofen is likely compatible with breastfeeding when appropriate infant monitoring is implemented.